438 related articles for article (PubMed ID: 24684609)
21. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
[TBL] [Abstract][Full Text] [Related]
22. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
Joel DD; Coderre JA; Micca PL; Nawrocky MM
J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
[TBL] [Abstract][Full Text] [Related]
23. L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours.
Watanabe T; Tanaka H; Fukutani S; Suzuki M; Hiraoka M; Ono K
Cancer Lett; 2016 Jan; 370(1):27-32. PubMed ID: 26455769
[TBL] [Abstract][Full Text] [Related]
24. The enhancement of neutron irradiation of HeLa-S cervix carcinoma cells by cell-nucleus-addressed deca-p-boronophenylalanine.
Braun K; Wolber G; Waldeck W; Pipkorn R; Jenne J; Rastert R; Ehemann V; Eisenmenger A; Corban-Wilhelm H; Braun I; Heckl S; Debus J
Eur J Med Chem; 2003 Jun; 38(6):587-95. PubMed ID: 12832130
[TBL] [Abstract][Full Text] [Related]
25. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of
Fukuda H; Hiratsuka J
Appl Radiat Isot; 2020 Dec; 166():109308. PubMed ID: 32823081
[TBL] [Abstract][Full Text] [Related]
28. Boron phenyl alanine targeted chitosan-PNIPAAm core-shell thermo-responsive nanoparticles: boosting drug delivery to glioblastoma in BNCT.
Soleimanbeigi M; Dousti F; Hassanzadeh F; Mirian M; Varshosaz J; Kasesaz Y; Rostami M
Drug Dev Ind Pharm; 2021 Oct; 47(10):1607-1623. PubMed ID: 35060826
[TBL] [Abstract][Full Text] [Related]
29. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
[TBL] [Abstract][Full Text] [Related]
30. Dynamic SIMS ion microscopy imaging of intracellular boron accumulation from carboranyl nucleosides in glioma cells.
Gay I; Lorey DR; Schinazi RF; Morrison GH; Chandra S
Anticancer Res; 2001; 21(4A):2369-75. PubMed ID: 11724295
[TBL] [Abstract][Full Text] [Related]
31. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
33. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
34. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2.
Wongthai P; Hagiwara K; Miyoshi Y; Wiriyasermkul P; Wei L; Ohgaki R; Kato I; Hamase K; Nagamori S; Kanai Y
Cancer Sci; 2015 Mar; 106(3):279-86. PubMed ID: 25580517
[TBL] [Abstract][Full Text] [Related]
35. Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of 10B-boronophenylalanine (10B-BPA) used in boron neutron capture therapy.
Pitois A; de las Heras LA; Zampolli A; Menichetti L; Carlos R; Lazzerini G; Cionini L; Salvatori PA; Betti M
Anal Bioanal Chem; 2006 Feb; 384(3):751-60. PubMed ID: 16372182
[TBL] [Abstract][Full Text] [Related]
36. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
[TBL] [Abstract][Full Text] [Related]
37. From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy.
Barth RF
Appl Radiat Isot; 2015 Dec; 106():22-8. PubMed ID: 26149807
[TBL] [Abstract][Full Text] [Related]
38. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
Yoshimoto M; Kurihara H; Honda N; Kawai K; Ohe K; Fujii H; Itami J; Arai Y
Nucl Med Biol; 2013 Jul; 40(5):625-9. PubMed ID: 23557719
[TBL] [Abstract][Full Text] [Related]
39. Similar T/N ratio between
Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ
Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410
[TBL] [Abstract][Full Text] [Related]
40. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]